Chemical Compound
Pitavastatin calcium
CAS Registry Number
147526-32-7
Primary Record
Pitavastatin calcium
- In stock
- 9,707 g
- Purity
- 98.5 %
- CAS
- 147526-32-7
Compound Identifiers & Properties
- CAS
- 147526-32-7
- PubChem CID
- 5282451
- SMILES
- C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2]
- Canonical SMILES
- O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]
Names & Synonyms
- Pitavastatin calcium
- Livalo
- Pitavastatin hemicalcium
- 147526-32-7
- Itavastatin
- Nisvastatin
- Pitavastatin
- Itavastatin calcium
- Alipza
- Flovas
- Livazo
- Redevant
- Vezepra
- Pitavastatin calcium salt
- Pitavastatin Calcuim
- Livalo (TN)
- Pitavastatin [INN]
- IYD54XEG3W
- Pitavastatin calcium?
- NK-104
- UNII-IYD54XEG3W
- NK 104 (acid)
- RefChem:56352
- DTXSID4046448
- MFCD01937979
- 2C25H23FNO4.Ca
- D0H9WN
- AC1NR03G
- Pitavastatin calcium (JAN)
- CCRIS 8652
- NK 104
- SCHEMBL22720
- MSK10417Ca
- CHEBI:71258
- C50H46CaF2N2O8
- UNII-M5681Q5F9P
- DTXCID40819916
- RHGYHLPFVJEAOC-FFNUKLMVSA-L
- C25H24FNO4
- orb1305347
- CHEMBL1237061
- SCHEMBL29359299
- C25H24FNO4.1/2Ca
- CHEBI:94569
- Pitavastatin hemicalcium;NK-104
- NKS-104
- PITAVASTATIN CALCIUM [JAN]
- ACT02718
- C25-H24-F-N-O4
- Tox21_112195
- Tox21_303926
- 2299AH
- EBC-11269
- NP3453
- PITAVASTATIN CALCIUM [MART.]
- PITAVASTATIN CALCIUM [WHO-DD]
- AKOS015900407
- PITAVASTATIN CALCIUM SALT [MI]
- ACN-048271
- AM84441
- AN-6862
- AT-3425
- CID5282451
- FP37016
- KS-1220
- C25-H24-F-N-O4.1/2Ca
- NCGC00164566-01
- NCGC00356953-01
- 111GE002
- BC654789
- BR-50694
- LS-74595
- PITAVASTATIN CALCIUM [ORANGE BOOK]
- SC-18906
- SY073052
- Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
- Pitavastatin calcium, 99% - 10MG 10mg
- AB2000276
- CAS-147526-32-7
- ST24030237
- A10737
- D01862
- P 872441
- P-872441
- A808654
- 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-
- calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
- calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
- Q27139472
- 147511-69-1
- Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt
- (+)-monocalciumbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-hepten
- 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))-
- calcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate}
- 6-heptenoicacid,7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydro
- ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
- (+) Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate]
- (+)- Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4- fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate]
- (+)-MONOCALCIUMBIS[(3R,5S,6E)-7-[2-CYCLOPROPYL-4(4-FLUOROPHENYL)-3-QUINOLYL]3,5-DIHYDROXY-6-HEPTENO ATE]
- (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
- (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid
- (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt
- (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt (2:1); 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), [S-[R*,S*-(E)]]-; (E)-(3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid hemicalcium salt; Flovas; Livalo; NK 104; NK 104 (acid); Pitava; Pitava 1; Pitavastatin calcium; Pitavastatin hemicalcium
- (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid hemicalcium salt
- 10031-30-8
- 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-,calcium salt (2:1), (3R,5S,6E)-
- Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate) monocalcium salt
- Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
- calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate
- calcium(2+) bis((3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)
- calcium,(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
- calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate
- Monocalcium bis[(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate]